Have a feature idea you'd love to see implemented?
Let us know!
BHC Bausch Health Companies Inc
Price (delayed)
$8.34
Market cap
$3.06B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.27
Enterprise value
$24.1B
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of
Highlights
BHC's gross profit is up by 11% year-on-year and by 2.6% since the previous quarter
The revenue has increased by 10% year-on-year and by 2.6% since the previous quarter
Bausch Health Companies's quick ratio has increased by 5% YoY but it has decreased by 3.1% from the previous quarter
The net income has plunged by 153% YoY and by 3.5% from the previous quarter
BHC's EPS has dropped by 149% year-on-year and by 3.3% since the previous quarter
Key stats
What are the main financial stats of BHC
Market
Valuations
Earnings
Shares outstanding
367.1M
Market cap
$3.06B
Enterprise value
$24.1B
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.33
EV/EBIT
22.13
EV/EBITDA
10.22
EV/Sales
2.62
Revenue
$9.2B
EBIT
$1.09B
EBITDA
$2.36B
Free cash flow
$911M
Per share
Balance sheet
Liquidity
EPS
-$1.27
Free cash flow per share
$2.48
Book value per share
-$3.2
Revenue per share
$25.01
TBVPS
$25.73
Total assets
$26.5B
Total liabilities
$26.72B
Debt
$21.66B
Equity
-$1.18B
Working capital
$842M
Debt to equity
-18.43
Current ratio
1.19
Quick ratio
0.62
Net debt/EBITDA
8.93
Margins
Efficiency
Dividend
EBITDA margin
25.6%
Gross margin
70.8%
Net margin
-5.1%
Operating margin
11.4%
Return on assets
-1.7%
Return on equity
N/A
Return on invested capital
4.1%
Return on capital employed
4.9%
Return on sales
11.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BHC stock price
How has the Bausch Health Companies stock price performed over time
Intraday
2.21%
1 week
3.35%
1 month
2.21%
1 year
24.66%
YTD
3.99%
QTD
2.21%
Financial performance
How have Bausch Health Companies's revenue and profit performed over time
Revenue
$9.2B
Gross profit
$6.52B
Operating income
$1.05B
Net income
-$471M
Gross margin
70.8%
Net margin
-5.1%
The net income has plunged by 153% YoY and by 3.5% from the previous quarter
The net margin has dropped by 132% year-on-year
The company's operating income has surged by 76% YoY but it fell by 2.2% QoQ
The operating margin has soared by 61% YoY but it has contracted by 4.2% from the previous quarter
Growth
What is Bausch Health Companies's growth rate over time
Valuation
What is Bausch Health Companies stock price valuation
P/E
N/A
P/B
N/A
P/S
0.33
EV/EBIT
22.13
EV/EBITDA
10.22
EV/Sales
2.62
BHC's EPS has dropped by 149% year-on-year and by 3.3% since the previous quarter
The company's equity has shrunk by 77% YoY and by 5% QoQ
The price to sales (P/S) is 53% lower than the 5-year quarterly average of 0.7 but 10% higher than the last 4 quarters average of 0.3
The revenue has increased by 10% year-on-year and by 2.6% since the previous quarter
Efficiency
How efficient is Bausch Health Companies business performance
The ROA has plunged by 143% YoY
BHC's return on sales is down by 27% year-on-year
BHC's return on invested capital is down by 25% year-on-year
Dividends
What is BHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BHC.
Financial health
How did Bausch Health Companies financials performed over time
The current ratio has grown by 6% YoY but it has contracted by 2.5% from the previous quarter
The total liabilities has grown by 6% YoY
The company's equity has shrunk by 77% YoY and by 5% QoQ
The debt to equity is up by 41% year-on-year and by 7% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.